Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by pidukson Jun 19, 2024 5:55pm
106 Views
Post# 36096826

Medipharm Labs formulation for generic Epidiolex

Medipharm Labs formulation for generic Epidiolex is NO WHERE near the same as JAZZ.   First of all JAZZ uses seasame oil to suspend the CBD which in itself can create problems and slow down absorption, therefore also in liquid form.   Medipharm Labs in tablet form with SEDDS technology for higher absorption is a generic form in the treatment of epilepsy but is no where near the same in terms of composition and delivery except for the CBD content. 

Any pharma's want to have exclusive rights to that **patented protected Epidiolex generic?  Call Elmer Fudd.   

**Patent No. US 11,998,632 B2
<< Previous
Bullboard Posts
Next >>